Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.03.2019 | Case report

Antineoplastics

Neuropathy and neuropsychological dysfunction: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Batra A, et al. Early experience with chemotherapy intensification for poor prognosis metastatic non-seminomatous germ cell cancer (mNSGCT) and unfavourable tumour marker decline (UTMD). Canadian Urological Association Journal 13 (Suppl. 2): S24 abstr. POS-2.7, No. 2, Feb 2019. Available from: URL: https://cuaj.ca/index.php/journal/article/view/5793/3970 [abstract] -Canada Batra A, et al. Early experience with chemotherapy intensification for poor prognosis metastatic non-seminomatous germ cell cancer (mNSGCT) and unfavourable tumour marker decline (UTMD). Canadian Urological Association Journal 13 (Suppl. 2): S24 abstr. POS-2.7, No. 2, Feb 2019. Available from: URL: https://​cuaj.​ca/​index.​php/​journal/​article/​view/​5793/​3970 [abstract] -Canada
Metadaten
Titel
Antineoplastics
Neuropathy and neuropsychological dysfunction: 2 case reports
Publikationsdatum
01.03.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-59204-2

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Voriconazole

Case report

Pegaspargase

Case report

Melphalan

Case report

Ustekinumab

Case report

Hydroxycarbamide